Shareholders' Equity (Details) (USD $)
|
3 Months Ended |
---|---|
Mar. 31, 2015
|
|
Shareholders' Equity [Abstract] | |
Warrants outstanding range of exercise price | $ 12.00pme_WarrantsOutstandingRangeOfExercisePrice |
Warrants outstanding number outstanding at March 31, 2015 | 8,966,667us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber |
Warrants outstanding weighted average remaining contractual life (years) | 2 years 10 months 24 days |
Warrants exercisable weighted average exercise price | $ 12.00pme_WeightedAverageExercisePriceOfWarrantsExercisable |
Warrants exercisable number exercisable at March 31, 2015 | 8,966,667us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised |
Warrants exercisable weighted average exercise price | $ 12.00pme_WarrantsExercisableWeightedAverageExercisePrice |
X | ||||||||||
- Definition
Warrants exercisable weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition
Warrants outstanding range of exercise price. No definition available.
|
X | ||||||||||
- Definition
Warrants outstanding weighted average remaining contractual life. No definition available.
|
X | ||||||||||
- Definition
Weighted average exercise price of warrants exercisable. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Number of non-option equity instruments exercised by participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|